Sulfonylurea compounds and their use in treating diabetes
    8.
    发明授权
    Sulfonylurea compounds and their use in treating diabetes 失效
    磺酰脲类化合物及其在治疗糖尿病中的应用

    公开(公告)号:US4505921A

    公开(公告)日:1985-03-19

    申请号:US529735

    申请日:1983-09-06

    摘要: New sulfonylurea compounds of the formula: ##STR1## in which n is 1 or 2,R is thienyl, furyl, pyridyl or phenyl optionally mono or disubstituted,R.sub.1 and R.sub.2, the same or different, each are hydrogen, halogen, (C.sub.1 to C.sub.5)-alkyl, (C.sub.1 to C.sub.5)-alkoxy, or trifluoromethyl, or together represent --CH.sub.2 --O--CH.sub.2 --,R.sub.3 is hydrogen, or hydroxy, andR.sub.4 is (C.sub.1 to C.sub.5)-alkyl, (C.sub.3 to C.sub.8)-cycloalkyl or azacycloalkyl of the formula: ##STR2## in which p is zero or an integer from 1 to 5, or azabicycloalkyl of the formula: ##STR3## in which m is 1, 2, or 3. These new compounds and physiologically tolerable salts thereof may be used as medicines especially in the treatment of diabetes.

    摘要翻译: 新的具有下式的磺酰脲化合物:其中n为1或2,R为噻吩基,呋喃基,吡啶基或苯基,任选单取代或二取代,R 1和R 2相同或不同,各自为氢,卤素,(C 1至 C 1 -C 5) - 烷基,(C 1 -C 5) - 烷氧基或三氟甲基,或一起表示-CH 2 -O-CH 2 - ,R 3为氢或羟基,且R 4为(C 1至C 5) - 烷基,(C 3至C 8) 环烷基或氮杂环烷基,其中p为0或1至5的整数,或下式的氮杂双环烷基:其中m为1,2或3.这些新化合物和生理上可耐受的 其盐可以用作药物,特别是用于治疗糖尿病。